Navigation Links
Study confirms difference in radical prostatectomy outcomes between surgeons
Date:3/18/2013

Milan, 18 March 2013 - New evidence from Sweden confirms previous studies which suggest that functional outcomes after radical prostatectomy may vary between surgeons, especially in relation to continence. However, the group found no evidence of heterogeneity in potency-related outcomes.

The results of this investigation, to be presented at the 28th Annual EAU Congress, aimed of to examine between surgeon variation with regards to oncological and patient-reported functional outcomes in one European centre.

The study included 1280 men who underwent open radical prostatectomy performed by one of nine surgeons at an academic institution in Sweden between 2 January 2001 through 16 July 2008.

Biochemical recurrence was defined as a prostate-specific antigen (PSA) value > 0.2 ng/ml with at least one confirmatory rise. The scientists measured functional outcomes preoperatively and postoperatively 18 months after the procedure by patient-administered questionnaires. Multivariate random effect models were used to evaluate heterogeneity between surgeons, adjusting for case mix which included age, PSA, pathological stage and grade - year of surgery and surgical experience.

Of 635 men potent at baseline, 606 provided data at 18 months, of whom 100/606 (17%) were potent (nerve-sparing and non-nerve-sparing surgery), suggesting the absence of heterogeneity between surgeons (p=0.5).

The continence rate at 18 months was 85%, revealing statistically significant heterogeneity between surgeons (p=0.002). There was evidence of an unexpected negative correlation between the surgeons' adjusted probabilities of potency and continence at 18 months. At the same time, the researchers did not find any association between surgeons' adjusted probabilities of functional recovery and 5-year probability of freedom from biochemical recurrence.

"Surgeon heterogeneity suggests that at least some patients are receiving suboptimal care," wri
'/>"/>

Contact: Ivanka Moerkerken
i.moerkerken@uroweb.org
31-026-389-0680
European Association of Urology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Consumers View Foods With Green Labeling as Healthier: Study
2. Study shows rising rate of propofol abuse by health care professionals
3. UK study: Epigenetic changes play a key role in development of chemo resistance in BCa
4. New study points to the aggressive potential of small kidney tumors, advocates treatment
5. New study: Incidence and mortality of PCa after termination of PSA-based screening
6. Study shows community approach effective in fight against diabetes
7. Study: Smoking Increases HPV Risks; polyDNA Recommends Gene-Eden-VIR Against HPV
8. Omega XL Reports New Independent Study: Omega-3s Can Boost Children’s IQ
9. Childhood Depression May Be Tied to Later Heart Risk: Study
10. Avoiding Scary Situations May Leave Kids More Anxious: Study
11. Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding Increased Metal Ion Levels May Predict Problems with Metal-on-Metal Hip Replacements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... Dennis Thompson HealthDay ... Babies born early or at low birth weight are at ... or health problems that increase their risk for heart disease, ... though these children face potential lifetime disadvantages, researchers in ... -- found that these obstacles can be overcome. ...
(Date:9/2/2014)... News) -- When it comes to excess pounds and blood ... study finds. The research found that belly fat -- ... high blood pressure more than overall body fat. It,s ... pressure. But it wasn,t clear how the location of fat ... University of Texas Southwestern Medical Center in Dallas. Reporting ...
(Date:9/2/2014)... Moroccan Eco-Biologics’ new one-of-a-kind Vitality Hair Recovery ... the foundation of all natural Moroccan plant extracts to ... There is nothing similar to Vitality Hair Recovery cream ... is a commonly encountered problem for men and women ... been limited to existing medications offering mediocre results, considerable ...
(Date:9/2/2014)... 2014 National law firm, ... has filed an application for attorneys’ fees and ... action litigation brought over Flushmate flushing mechanisms. In ... Counsel in this litigation includes Birka-White Law Offices; ... Partners, LLP; Levin Fishbein, Sedran & Berman, LLP; ...
(Date:9/2/2014)... Florida (PRWEB) September 02, 2014 ... Accredited teleradiology and telemedicine solutions provider, including SecondOpinions.com® ... its innovative and technologically advanced services. The telemedicine ... Shifa Hospital in Kuwait. , Founded and established ... Kuwait, Dar Al Shifa began as a maternity ...
Breaking Medicine News(10 mins):Health News:Preterm or Small Birth Tied to Long-Term Risks to Heart, Brain 2Health News:Preterm or Small Birth Tied to Long-Term Risks to Heart, Brain 3Health News:'Spare Tire' May Be Especially Bad for Your Blood Pressure 2Health News:New All Natural, Organic Hair Recovery Products by Moroccan Eco-Biologics, Restore Lost Hair with No Side Effects 2Health News:A Proposed Order Has Been Submitted in A Class Action Law Suit Brought Over Flushmate Toilets, Parker Waichman Announces 2Health News:A Proposed Order Has Been Submitted in A Class Action Law Suit Brought Over Flushmate Toilets, Parker Waichman Announces 3Health News:USARAD Holdings Inc. SECONDOPINIONS.COM® Partners With Prestigious Dar Al Shifa Hospital In Kuwait 2Health News:USARAD Holdings Inc. SECONDOPINIONS.COM® Partners With Prestigious Dar Al Shifa Hospital In Kuwait 3Health News:USARAD Holdings Inc. SECONDOPINIONS.COM® Partners With Prestigious Dar Al Shifa Hospital In Kuwait 4
... PhD, a physician-scientist in the Hematology/Oncology Divison at Beth ... at Harvard Medical School has received a Young Investigator ... $225,000 award, one of 21 made to young scientists ... encourage the most innovative minds in cancer research to ...
... years and younger living in Tanzania. With limited ... positive and significant impact on what these children learn? ... version of Sesame Street, recently commissioned researchers from the ... collaboration with a Dar es Salaam-based research team, to ...
... at the Stanford University School of Medicine have identified ... significant because the existence of such a cell in ... debate. It may also explain why current immunotherapies are ... "These cells lack the traditional melanoma cell ...
... ... mollis. Aenean cursus, nisi id congue convallis, risus augue pulvinar sem, nec ultricies nulla ... In placerat eleifend felis in commodo. , ... Freistatt, MO (PRWEB) June 30, 2010 -- Lorem ipsum dolor ...
... By Dennis Thompson HealthDay Reporter , WEDNESDAY, ... reached a point of significant potential, even as the disease,s ... say. Some leading scientists, in fact, worry that we ... advances and new insights into Alzheimer,s, the most common type ...
... improving the environment in life may soon be able to ... new and unusual methods of body disposal including a ... bodies into soil that could provide environmentally friendly alternatives ... article in the current issue of Chemical & Engineering News ...
Cached Medicine News:Health News:BIDMC researcher receives Young Investigator Award from Prostate Cancer Foundation 2Health News:Kilimani Sesame has positive impact on children in Tanzania: Johns Hopkins University study 2Health News:Melanoma-initiating cell identified by Stanford scientists 2Health News:Melanoma-initiating cell identified by Stanford scientists 3Health News:Melanoma-initiating cell identified by Stanford scientists 4Health News:Lorem ipsum dolor sit amet, consectetur adipiscing elit. Fusce ornare dictum nunc 2Health News:Experts Optimistic About Solving Puzzle of Alzheimer's 2Health News:Experts Optimistic About Solving Puzzle of Alzheimer's 3Health News:Experts Optimistic About Solving Puzzle of Alzheimer's 4
(Date:9/2/2014)... ResMed (NYSE: RMD ) has introduced ... the United States . The Astral platform ... life support ventilators. ResMed,s new Astral ... use for patients suffering from neuromuscular disease, chronic obstructive ... disorders. The U.S. launch comes on the heels of ...
(Date:9/2/2014)... 2014  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ... Administration (FDA) has granted orphan drug status to APD811 ... "The FDA Office of Orphan Products Development (OOPD) ... identify and designate drug candidates that could potentially treat ... of such products," said Craig M. Audet , ...
(Date:9/2/2014)... 2014   Intrexon Corporation (NYSE: ... that it has entered into an Exclusive Channel Collaboration ... Sanofi (EURONEXT: SAN and NYSE: SNY ) ... family of its marketed Active Pharmaceutical Ingredients (APIs) through ... . This collaboration will leverage Intrexon,s proprietary technology suite ...
Breaking Medicine Technology:ResMed's Revolutionary Life Support Ventilation Platform -- Astral 100 and 150 Devices Now Available in the U.S. 2ResMed's Revolutionary Life Support Ventilation Platform -- Astral 100 and 150 Devices Now Available in the U.S. 3Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 2Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 3Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 4Intrexon Announces Exclusive Channel Collaboration with Sanofi to Optimize Production for a Specific Family of Active Pharmaceutical Ingredients 2Intrexon Announces Exclusive Channel Collaboration with Sanofi to Optimize Production for a Specific Family of Active Pharmaceutical Ingredients 3
Inquire...
Inquire...
... The compact Allegra X-22 Series is up to ... With a library of 11 rotors, the Allegra X-22 ... Features: Only 18 inches / 46 ... to 22,065 x g 3 different ways to ...
... Fractionation, Proteins and Viruses • ... with fixed-angle rotor • Spin ... 85 mL • Operating temperature ... C • Rotors certified by ...
Medicine Products: